|
Report No. : |
337981 |
|
Report Date : |
28.08.2015 |
IDENTIFICATION DETAILS
|
Name : |
SHANDONG JINCHENG KERUI CHEMICAL CO., LTD. |
|
|
|
|
Registered Office : |
Dongzhang Village, Sibaoshan, High-New Technology Development Zone,
Zibo City, Shandong Province 255000 Pr |
|
|
|
|
Country : |
China |
|
|
|
|
Financials (as on) : |
31.12.2014 |
|
|
|
|
Date of Incorporation : |
12.05.2005 |
|
|
|
|
Com. Reg. No.: |
370300018517369 |
|
|
|
|
Legal Form : |
One-Person Limited Liability Company |
|
|
|
|
Line of Business : |
Subject is engaged in production and sales in the scope of the
approval of the product approval certificate for the chemical production enterprise;
importing and exporting commodities. |
|
|
|
|
No. of Employees : |
350 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
China |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
CHINA - ECONOMIC OVERVIEW
Since the late 1970s China has moved from a closed, centrally planned system to a more market-oriented one that plays a major global role - in 2010 China became the world's largest exporter. Reforms began with the phasing out of collectivized agriculture, and expanded to include the gradual liberalization of prices, fiscal decentralization, increased autonomy for state enterprises, growth of the private sector, development of stock markets and a modern banking system, and opening to foreign trade and investment. China has implemented reforms in a gradualist fashion. In recent years, China has renewed its support for state-owned enterprises in sectors considered important to "economic security," explicitly looking to foster globally competitive industries. The restructuring of the economy and resulting efficiency gains have contributed to a more than tenfold increase in GDP since 1978. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, China in 2014 stood as the largest economy in the world, surpassing the US for the first time in modern history. Still, China's per capita income is below the world average.
After keeping its currency tightly linked to the US dollar for years, in July 2005 China moved to an exchange rate system that references a basket of currencies. From mid 2005 to late 2008 cumulative appreciation of the renminbi against the US dollar was more than 20%, but the exchange rate remained virtually pegged to the dollar from the onset of the global financial crisis until June 2010, when Beijing allowed resumption of a gradual appreciation. In 2014 the People’s Bank of China (PBOC) doubled the daily trading band within which the RMB is permitted to fluctuate.
The Chinese government faces numerous economic challenges, including: (a) reducing its high domestic savings rate and correspondingly low domestic consumption; (b) facilitating higher-wage job opportunities for the aspiring middle class, including rural migrants and increasing numbers of college graduates; (c) reducing corruption and other economic crimes; and (d) containing environmental damage and social strife related to the economy's rapid transformation. Economic development has progressed further in coastal provinces than in the interior, and by 2014 more than 274 million migrant workers and their dependents had relocated to urban areas to find work. One consequence of population control policy is that China is now one of the most rapidly aging countries in the world. Deterioration in the environment - notably air pollution, soil erosion, and the steady fall of the water table, especially in the North - is another long-term problem. China continues to lose arable land because of erosion and economic development. The Chinese government is seeking to add energy production capacity from sources other than coal and oil, focusing on nuclear and alternative energy development.
Several factors are converging to slow China's growth, including debt overhang from its credit-fueled stimulus program, industrial overcapacity, inefficient allocation of capital by state-owned banks, and the slow recovery of China's trading partners. The government's 12th Five-Year Plan, adopted in March 2011 and reiterated at the Communist Party's "Third Plenum" meeting in November 2013, emphasizes continued economic reforms and the need to increase domestic consumption in order to make the economy less dependent in the future on fixed investments, exports, and heavy industry. However, China has made only marginal progress toward these rebalancing goals. The new government of President XI Jinping has signaled a greater willingness to undertake reforms that focus on China's long-term economic health, including giving the market a more decisive role in allocating resources. In 2014 China agreed to begin limiting carbon dioxide emissions by 2030. China also implemented several economic reforms in 2014, including passing legislation to allow local governments to issue bonds, opening several state-owned enterprises to further private investment, loosening the one-child policy, passing harsher pollution fines, and cutting administrative red tape.
|
Source
: CIA |
SHANDONG JINCHENG KERUI CHEMICAL
CO., LTD.
DONGZHANG VILLAGE, SIBAOSHAN
HIGH-NEW TECHNOLOGY DEVELOPMENT ZONE, ZIBO CITY
SHANDONG PROVINCE 255000 PR CHINA
TEL: 86 (0) 533-2072886/2072887
FAX: 86 (0) 533-5439426
Date of Registration : MAY 12, 2005
REGISTRATION NO. : 370300018517369
LEGAL FORM : ONE-PERSON LIMITED
LIABILITY COMPANY
CHIEF EXECUTIVE :
guo fangshui (LEGAL REPRESENTATIVE)
REGISTERED CAPITAL : cny 61,000,000
staff :
350
BUSINESS CATEGORY :
manufacturing & trading
Revenue :
CNY 252,183,000 (AS OF DEC. 31,
2014)
EQUITIES :
CNY 214,264,000 (AS OF DEC. 31, 2014)
WEBSITE : N/A
E-MAIL :
N/A
PAYMENT :
AVERAGE
MARKET CONDITION : COMPETITIVE
FINANCIAL CONDITION : FAIRly good
OPERATIONAL TREND :
fairly STEADY
GENERAL REPUTATION : AVERAGE
EXCHANGE RATE :
CNY 6.41 = USD 1
Adopted
abbreviations (as follows)
SC - Subject Company
(the company inquired by you)
N/A – Not available
CNY – China Yuan Ren
Min Bi
This section aims at indicating the relative positions of SC in respect
of its operational trend & general reputation
Operational Trend:- General
Reputation:-
Upward Excellent
Steady Good
Fairly Steady Fairly
Good
Ordinary Average
Fair Fair
Stagnant Detrimental
Downward Not
known
Not known Not
yet be determined
Not yet be determined
SC was established as a Chinese-foreign equity joint venture enterprise
of PRC on May 12, 2005. However, SC changed to
present legal form, and was registered as one-person limited liabilities
company of PRC with State Administration of Industry & Commerce (SAIC)
under registration No.: 370300018517369 on September 28, 2007.
SC’s Organization Code Certificate No.:
77316311-9

SC’s registered capital: cny 61,000,000
SC’s paid-in capital: cny 61,000,000
Registration Change Record:-
|
Date |
Change of Contents |
Before the change |
After the change |
|
2007-9-28 |
Shareholder (s) (% of Shareholding) |
Sinuo-American Trade Co., Ltd.(In Chinese Pinyin) 25% Shandong Jincheng
Pharmaceutical & Chemical Co., Ltd. 75% |
Shandong
Jincheng Pharmaceutical & Chemical Co., Ltd. 100% |
|
Registered Capital |
CNY 12,000,000 |
CNY 93,492,448 |
|
|
Legal Form |
Chinese-Foreign Equity Joint Venture Enterprise |
One-Person Limited Liabilities Company |
|
|
2007-11-12 |
Registered Capital |
CNY 93,492,448 |
CNY 36,000,000 |
|
2008-4-3 |
Shareholder’s Chinese Name |
|
|
|
-- |
Registered Capital |
CNY 36,000,000 |
cny 61,000,000 |
|
-- |
Legal Representative |
Zhao Hongfu |
Guo Fangshui |
Current Co search indicates SC’s shareholders & chief executives are
as follows:-
|
Name of Shareholder (s) |
% of Shareholding |
|
Shandong
Jincheng Pharmaceutical & Chemical Co., Ltd. |
100 |
SC’s Chief Executives:-
|
Position |
Name |
|
Legal Representative, Chairman and General Manager |
Guo Fangshui |
|
Director |
Li Jiaquan |
|
Zhao Yeqing |
|
|
Zhang Xuebo |
|
|
Supervisor |
Sun Ruihai |
|
Sun Bin |
No recent development was found during our checks at present.
Name %
of Shareholding
Shandong Jincheng Pharmaceutical & Chemical Co., Ltd. 100
------------------------------------------
Registration No.: 370300018517205
Legal Form: Shares Limited
Company
Chief Executive: Zhao Yeqing
Registered Capital: CNY 126,600,000
Address: No. 26, Kunxin Road, Zichuan District, Zibo City, Shandong
Province, China
Tel: +86-533-5439411
Fax: +86-533-5776517, 5772739, 5439426
Website: http://www.jcpcol.com
Email: jcpc@jinchengpharm.com
Guo Fangshui,
Legal Representative, Chairman and General Manager
-------------------------------------------------------------------------------------------------------
Gender: M
Qualification: University
Working experience (s):
At present, working in SC as legal representative, chairman and general
manager
Director
-----------
Li Jiaquan
Zhao Yeqing
Zhang Xuebo
Supervisor
--------------
Sun Ruihai
Sun Bin
SC’s registered business scope includes production and sales in the
scope of the approval of the product approval certificate for the chemical production
enterprise; importing and exporting commodities.
SC is mainly engaged in manufacturing and selling pharmaceutical &
chemical products.
SC’s products mainly include: pharmaceutical products, mainly
ceftazidime dihydrochloride, BEAM, cefixime open side chain acid, etc.
SC sources its materials 100% from domestic market. SC sells 100% of its
products to overseas market.
The buying terms of SC include T/T and Credit of 30-60 days. The payment
terms of SC include T/T, L/C and Credit of 30-60 days.
Staff &
Office:
--------------------------
SC is known to have approx. 350
staff at present.
SC owns an area as its operating office & factory of approx. 60,000
sq. meters at the heading address.
Shandong Huihai Pharmaceutical & Chemical Co., Ltd.
Shandong Jincheng Zhonghua Biopharmaceuticals Co., Ltd.
Overall payment appraisal: ( ) Excellent ( ) Good (X) Average ( ) Fair ( ) Poor ( ) Not yet be determined
The appraisal serves as a reference to reveal SC's payments habits and
ability to pay. It is based on the 3
weighed factors: Trade payment experience (through current enquiry with SC's
suppliers), our delinquent payment and our debt collection record concerning
SC.
Trade payment experience: SC did not provide any name of
trade/service suppliers and we have no other sources to conduct the enquiry at
present.
Delinquent payment record: None in our database.
Debt collection record: No overdue amount owed
by SC was placed to us for collection within the last 6 years.
Basic Bank:
Bank of
Communications Zibo Branch Zichuan Sub-branch
AC#: 373030602018010070053
Balance Sheet
|
Unit: CNY’000 |
As of Dec. 31,
2013 |
As of Dec. 31,
2014 |
|
Cash |
12,056 |
36,374 |
|
Notes receivable |
10,490 |
3,027 |
|
Accounts receivable |
86,693 |
76,908 |
|
Advances to suppliers |
13,696 |
6,393 |
|
Other receivable |
22,096 |
48,428 |
|
Inventory |
22,104 |
34,648 |
|
Prepaid expenses |
0 |
0 |
|
Other current assets |
0 |
0 |
|
|
------------------ |
------------------ |
|
Current assets |
167,135 |
205,778 |
|
Long-term investment |
4,800 |
4,800 |
|
Fixed assets |
143,528 |
154,492 |
|
Construction in progress |
2,548 |
827 |
|
Intangible assets |
17,477 |
16,804 |
|
Long-term prepaid expenses |
0 |
0 |
|
Deferred income tax assets |
975 |
2,554 |
|
Other non-current assets |
0 |
2,207 |
|
|
------------------ |
------------------ |
|
Total assets |
336,463 |
387,462 |
|
|
============= |
============= |
|
Short-term loans |
66,000 |
96,000 |
|
Notes payable |
3,858 |
13,070 |
|
Accounts payable |
47,622 |
29,795 |
|
Wages payable |
7,168 |
9,229 |
|
Taxes payable |
44 |
4,319 |
|
Advances from clients |
0 |
0 |
|
Other payable |
2,720 |
15,308 |
|
Accrued expenses |
0 |
0 |
|
Other current liabilities |
0 |
0 |
|
|
------------------ |
------------------ |
|
Current liabilities |
127,412 |
167,721 |
|
Non-current liabilities |
1,811 |
5,477 |
|
|
------------------ |
------------------ |
|
Total liabilities |
129,223 |
173,198 |
|
Equities |
207,240 |
214,264 |
|
|
------------------ |
------------------ |
|
Total liabilities & equities |
336,463 |
387,462 |
|
|
============= |
============= |
Income Statement
|
Unit: CNY’000 |
As of Dec. 31,
2014 |
|
Revenue |
252,183 |
|
Cost of sales |
180,389 |
|
Taxes and surcharges |
1,741 |
|
Sales expense |
4,022 |
|
Management expense |
41,649 |
|
Finance expense |
4,367 |
|
Non-operating income |
961 |
|
Non-operating expense |
772 |
|
Profit before tax |
20,204 |
|
Less: profit tax |
3,181 |
|
Profits |
17,023 |
Important Ratios
=============
|
|
As of Dec. 31,
2013 |
As of Dec. 31,
2014 |
|
*Current ratio |
1.31 |
1.23 |
|
*Quick ratio |
1.14 |
1.02 |
|
*Liabilities to assets |
0.38 |
0.43 |
|
*Net profit margin (%) |
-- |
6.75 |
|
*Return on total assets (%) |
-- |
4.39 |
|
*Inventory / Revenue ×365 |
-- |
51 days |
|
*Accounts receivable / Revenue ×365 |
-- |
112 days |
|
*Revenue / Total assets |
-- |
0.65 |
|
*Cost of sales / Revenue |
-- |
0.72 |
PROFITABILITY:
FAIRLY GOOD
The revenue of SC appears fairly good in its line in 2014.
SC’s net profit margin is fairly good in 2014.
SC’s return on total assets is fairly good in 2014.
SC’s cost of sales is average, comparing with its revenue.
LIQUIDITY: AVERAGE
The current ratio of SC is maintained in a normal level.
SC’s quick ratio is maintained in a normal level.
The inventory of SC is maintained in an average level.
The accounts receivable of SC appears large.
SC’s short-term loans appear large.
SC’s revenue is in an average level, comparing with the size of its
total assets.
LEVERAGE: FAIRLY
GOOD
The debt ratio of SC is low.
The risk for SC to go bankrupt is average.
Overall financial
condition of the SC: Fairly Good.
SC is considered medium-sized in its line with fairly good financial
conditions.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.66.06 |
|
|
1 |
Rs.102.35 |
|
Euro |
1 |
Rs.74.97 |
INFORMATION DETAILS
|
Analysis Done by
: |
TRI |
|
|
|
|
Report Prepared
by : |
TPT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.